Abdel-Aleem S, Youssef J, Frangakis C, Badr M
Glaxo Research Institute, Glaxo Inc. Research Triangle Park, NC 27709.
Life Sci. 1992;51(1):53-7. doi: 10.1016/0024-3205(92)90218-e.
Although beta-oxidation of fatty acids occurs in both peroxisomes and mitochondria, beta-oxidizing enzymes in these organelles have distinct differences in their specifity and sensitivity to inhibitors. In this study, the effects of the phosphodiesterase inhibitor enoximone on hepatic peroxisomal and mitochondrial beta-oxidation were investigated. In liver homogenates from control rats, cyanide-insensitive peroxisomal beta-oxidation of palmitoyl-CoA was inhibited progressively by increasing concentrations of enoximone. Similar results were obtained in liver homogenates from rats pretreated with the known peroxisomal proliferator diethylhexylphthalate. In contrast, mitochondrial beta-oxidation of palmitoyl-CoA was not inhibited by enoximone. These data show that enoximone selectively inhibits basal as well as induced peroxisomal, but not mitochondrial, beta-oxidation of the CoA thioester of long-chain fatty acids. The availability of specific inhibitors of peroxisomal beta-oxidation should prove useful in elucidating regulatory mechanisms operative in this pathway in normal as well as in proliferated peroxisomes.
尽管脂肪酸的β-氧化作用在过氧化物酶体和线粒体中均会发生,但这些细胞器中的β-氧化酶在其特异性和对抑制剂的敏感性方面存在明显差异。在本研究中,对磷酸二酯酶抑制剂依诺昔酮对肝脏过氧化物酶体和线粒体β-氧化的影响进行了研究。在对照大鼠的肝脏匀浆中,随着依诺昔酮浓度的增加,对棕榈酰辅酶A的氰化物不敏感的过氧化物酶体β-氧化作用逐渐受到抑制。在用已知的过氧化物酶体增殖剂邻苯二甲酸二乙基己酯预处理的大鼠的肝脏匀浆中也获得了类似的结果。相比之下,依诺昔酮并未抑制棕榈酰辅酶A的线粒体β-氧化。这些数据表明,依诺昔酮选择性地抑制基础以及诱导的过氧化物酶体β-氧化作用,但不抑制长链脂肪酸辅酶A硫酯的线粒体β-氧化。过氧化物酶体β-氧化特异性抑制剂的可用性应有助于阐明在正常以及增殖的过氧化物酶体中此途径中起作用的调节机制。